Free case Evaluation Get startedbutton-icon

Zantac contains the substance NDMA which has been linked to a number of cancers including bladder cancer, brain cancer, breast cancer, esophageal/nasal/throat cancer, intestinal cancer, kidney cancer, liver cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, stomach cancer, testicular cancer, thyroid cancer, uterine cancer, and other cancers.

Anyone who previously took Zantac & has been subsequently diagnosed with cancer may qualify to participate in the Zantac Lawsuit.

Yes. The Zantac class action lawsuit was filed on behalf of individuals who used Zantac but were not diagnosed with cancer.

Many individual Zantac cancer lawsuits are being consolidated into a multidistrict litigation filed against Zantac manufacturer Sanofi in the Southern District of Florida.

The Zantac class-action has been consolidated in the Southern District of Florida.

The FDA issued a recall of all prescription and over-the-counter versions of Zantac in April 2020.

related areas of practice

What is Zantac?

Zantac is the trade name for Ranitidine, a popular heartburn medication that reduces the body’s production of stomach acid. The medication is commonly used to treat and prevent ulcers of the stomach and intestines as well as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, peptic ulcer disease, acid indigestion, and heartburn.

Zantac is available both over-the-counter and by prescription.

Ranitidine belongs to the h2 (histamine-2) blockers class of drugs. OTC Zantac is most commonly used to relieve and prevent heartburn, while the prescription-strength drug is used to prevent more serious ulcers and conditions.

The drug came into commercial use in 1981 and is now the 50th most prescribed medication in the United States.

 

Zantac Contains Carcinogen NDMA

Research revealed that the primary active ingredient in Zantac and similar generic products, ranitidine, contains NDMA, a possible chemical carcinogen. Manufacturers failed to warn consumers that Zantac contained NDMA, putting consumers at risk of cancer.

FDA Warning – Ranitidine Containing NDMA Poses Cancer Risk

The U.S. Food and Drug Administration (FDA) reported an advisory on September 13, 2019, after discovering the carcinogenic contaminant NDMA in ranitidine, the active ingredient in Zantac, at levels between 3,000 to 26,000 times higher than FDA approved standards.

The FDA acceptable threshold of daily NDMA intake is set at below 100 nanograms. The plaintiffs cited a study that claims that a 150-milligram pill of Zantac contains over 2.5 million nanograms of NDMA. Over-the-counter Zantac is typically sold in 150-milligram tablets; the recommended dosage to treat peptic ulcer disease for adults is 300 milligrams a night for four to eight weeks.

Plaintiffs allege that Sanofi and Boehringer Ingleham knew the risks of NDMA formation in ranitidine and did not alert the public through the drug’s label or through any other means. Several published studies have shown that ranitidine users have a 400-fold increase of NDMA concentration in their urine. The suit attests that had consumers known the risks, they would not have purchased or consumed ranitidine.

 

Ranitidine Products Containing NDMA

These are the most common Zantac products and generic Zantac products containing ranitidine:

  • Zantac 150 Tablets
  • Zantac 150 Maximum Strength
  • Zantac 150 Maximum Strength Cool Mint
  • Zantac 75 Tablets
  • Wal-Zan 150
  • Wal-Zan 75
  • Heartburn Relief
  • Acid Reducer
  • Acid Control

 

Zantac Cancer Risk

Zantac and other ranitidine-containing products may put consumers at risk of a number of adverse health risks including cancer.

Zantac Injuries

NDMA, n-nitrosodimethylamine, is a potential hepatotoxic, and exposure has been linked to numerous serious complications and symptoms ranging from:

  • Cancer
  • Liver fibrosis and scarring
  • Tumors in the liver, kidneys, and lungs.

 

Other symptoms of NDMA exposure include:

  • Headaches
  • Fever
  • Nausea
  • Jaundice
  • Vomiting
  • Abdominal cramps
  • Enlarged liver
  • Dizziness
  • Reduced function of the liver, kidneys, and lungs.

 

The World Health Organization described NDMA as a chemical that is “clearly carcinogenic.”

The U.S. Food and Drug Administration is working alongside regulators and industry partners to discover the source of impurities in ranitidine. The FDA is examining ranitidine NDMA levels and evaluating the potential risk to patients. The investigation is ongoing, and the agency plans to take appropriate measures.

 

Types of Cancers Linked to Zantac

Plaintiffs in the Zantac class-action lawsuit have a variety of cancers, including:

  • Bladder Cancer
  • Brain Cancer
  • Breast Cancer
  • Esophageal/Nasal/Throat Cancer
  • Intestinal Cancer
  • Kidney Cancer
  • Liver Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Uterine Cancer
  • Other Cancers

 

Zantac Recall

The FDA issued a recall of all prescription and over-the-counter versions of Zantac in April 2020.

After determining the levels of NDMA to be dangerous to consumers, the FDA called for patients to stop taking ranitidine and the agency has requested that the manufacturers recall the product and discontinue production of both Zantac and generic Zantac drugs.

Prior to this decision, some companies such as CVS, Walmart, and Sandoz have chosen to voluntarily suspend the sales of Zantac while waiting for results from ongoing tests and research.

Zantac Lawsuit

Both class-action lawsuits and civil lawsuits have been filed against the manufacturers of Zantac. These are separate types of lawsuits. It is important that you recognize which legal action is most appropriate for you before pursuing a Zantac lawsuit. For assistance in determining your best legal action, contact TorHoerman Law for a free, no-obligation case consultation.

Zantac Class-Action Lawsuit

The makers of Zantac, a popular over-the-counter and prescription heartburn medication, are facing a Zantac class-action lawsuit claiming the drug contains unsafe levels of the cancer-causing substance N-Nitrosodimethylamine (NDMA).

The U.S. Food and Drug Administration (FDA) reported an advisory on September 13, 2019, after discovering the carcinogenic contaminant NDMA in ranitidine, the active ingredient in Zantac, at levels between 3,000 to 26,000 times higher than FDA approved standards.

NDMA is a potential hepatotoxic, and exposure has been linked to numerous complications and symptoms ranging from bladder cancer, stomach cancer, liver fibrosis and scarring, and tumors in the liver, kidneys, and lungs. Other symptoms of NDMA exposure include headaches, fever, nausea, jaundice, vomiting, abdominal cramps, enlarged living, dizziness, and reduced function of the liver, kidneys, and lungs.

Plaintiffs accuse drugmakers Sanofi and Boehringer Ingelheim of manufacturing and marketing a medication they knew, or should have known, to be contaminated with the cancer-causing chemical without disclosing the risks to consumers or the government.

a Zantac class-action lawsuit has been filed against the manufacturers for concealing adverse health risks associated with Zantac that led plaintiffs to suffer serious injury and death.

 

NOTICE: TorHoerman Law is not involved in the Zantac class-action lawsuit.

 

 

Zantac Cancer Lawsuit

The makers of Zantac, a popular heartburn medication, are facing a Zantac cancer lawsuit claiming the drug contains unsafe levels of the cancer-causing substance N-Nitrosodimethylamine (NDMA) which caused plaintiffs to develop cancer.

Plaintiffs accuse drugmakers Sanofi and Boehringer Ingelheim of manufacturing and marketing a medication they knew, or should have known, to be contaminated with the cancer-causing chemical without disclosing the risks to consumers or the government. The manufacturer’s failure to warn directly lead to plaintiffs developing a number of life-threatening types of cancer.

 

Notice: TorHoerman Law is involved in the Zantac Cancer Lawsuit. Our firm is currently accepting new clients for the Zantac Lawsuit. If you believe that you have a case, contact TorHoerman Law for a free, no-obligation case consultation with an experienced Zantac Lawyer. You can also use our chatbot to receive a free, instant online case evaluation right now.

 

Zantac Cancer Lawsuit vs Zantac Class-Action Lawsuit

Which type of Zantac Lawsuit should you file?

If you took Zantac consistently and did not develop cancer, but were unaware of the cancer risks associated with Zantac, you may be eligible to participate in the Zantac class-action lawsuit.

The Zantac class-action lawsuit will likely compensate a percentage of the money you paid over time for Zantac products.

The award will be split evenly amongst class members

If you took Zantac and were subsequently  diagnosed with cancer, you may qualify for a Zantac cancer lawsuit.

The Zantac cancer lawsuit will compensate a percentage of the total damages that you incurred as a result of your cancer diagnosis including but not limited to: medical bills, lost income, future medical bills, future lost income, pain & suffering, loss of enjoyment of life, loss of life, and other losses.

The award will reflect your personal losses.

Filing a Zantac Lawsuit

TorHoerman Law is currently accepting new clients in the Zantac Cancer Lawsuit. Our firm is not currently accepting new clients in the class-action lawsuit.

A Zantac cancer lawsuit has been filed claiming that Zantac containing NDMA caused plaintiffs to develop cancer, which was not a health risk  listed on the Zantac warning label.

Before filing a  Zantac lawsuit, you should familiarize yourself with the steps of the civil litigation process so that you are aware of the process of a Zantac lawsuit.

 

Mitigating Damages

You should also do everything possible to mitigate your injuries.

This includes:

  • Discontinuing Zantac usage
  • Seeking proper medical care
  • Getting a diagnosis for injuries
  • Following the doctor’s orders
  • Doing everything in your power to minimize the costs and losses associated with injuries

 

Mitigation is extremely important in the process of building a strong and honest case with facts.

 

Hiring a Zantac Lawyer

The first step after mitigation is hiring a personal injury attorney who has experience handling bad drug lawsuits.

In the unfortunate event that you are representing a loved one who has died as a result of injuries from Zantac, you may need to consult with a wrongful death attorney who has knowledge of the Zantac lawsuit.

Your Zantac lawyer will work to:

  • Gather evidence
  • Establish liability
  • Assess damages
  • Navigate the litigation process
  • Get you compensated for your losses

 

Evidence

Evidence will help to prove the total cost of losses that you endured as a result of your injury, also known as your damages.

Your attorney will assist you in gathering evidence, but it is helpful if you start gathering evidence yourself as soon as you find out about your injury.

 

Common types of evidence in a Zantac lawsuit include:

  • Receipts of purchase of Zantac
  • Medical records & bills
  • Personal accounts of injury, such as journals
  • Photos & videos of injury progression
  • Proof of time off from work
  • Proof of other costs associated with injury

 

Damages

Damages are the total lossses, both non-economic and economic, that an injured party incurs as a result of their injury.

In many personal injury lawsuits, the injured party will choose to file for both compensatory damages and punitive damages. After assessing all damages that you incurred, your Zantac attorney will file a complaint demanding compensation to repay your damages.

 

Common damages in a Zantac Lawsuit include:

  • Medical expenses resulting from injuries
  • Future medical expenses resulting from the injuries
  • Pain and suffering, both physical and mental, caused by the injuries, treatment, and recovery period
  • Wage loss, loss of earning capacity
  • Other costs associated with our injuries
  • Loss of enjoyment of life resulting from damages
  • Loss of life
  • Punitive damages against the manufacturer

 

Do I Qualify For the Zantac Cancer Lawsuit?

If you or a loved one previously used Zantac or similar products & were subsequently diagnosed with cancer, you may qualify to file a Zantac lawsuit.

Contact TorHoerman Law for a free, no-obligation case consolation with a Zantac cancer lawyer to discuss your legal options today.

Want to find out if you qualify for compensation right away? Use our chatbot below to receive a free, instant online case evaluation right now!

 

TorHoerman Law, Experienced Zantac Lawyers

At TorHoerman Law, our team of personal injury attorneys is available any time to discuss your Zantac lawsuit. We offer free no-obligation case consultations for all potential clients.

Our services are based on contingency fees, so we never charge our clients a dime until they have received compensation first.

With over 100 years in combined litigation experiences and client awards exceeding $4 billion in verdicts & negotiated settlements for litigations we have been involved in, we let our experience and results speak for themselves.

Contact TorHoerman Law to talk to a Zantac lawyer and learn about your legal options, including filing a Zantac cancer lawsuit.

 

 

Client Reviews

SCROLL FOR MORE

TorHoerman Law is an awesome firm to represent anyone that has been involved in a case that someone has stated that it's too difficult to win. The entire firm makes you feel like you’re part of the family, Tor, Eric, Jake, Kristie, Chad, Tyler, Kathy and Steven are the best at what they do.

They helped my elderly uncle receive compensation for the loss of his wife who was administered a dangerous drug. He consulted with this firm because of my personal recommendation and was very pleased with the compassion, attention to detail and response he received. Definitely recommend this firm for their 5 star service.

When I wanted to join the Xarelto class action lawsuit, I chose TorrHoerman Law from a search of a dozen or so law firm websites. I was impressed with the clarity of the information they presented. I gave them a call, and was again impressed, this time with the quality of our interactions.

THANK YOU FOR YOUR MESSAGE

One of our associates will follow up with you shortly